Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Inna D'Empaire, MD

Articles by Inna D'Empaire, MD

Ktsdesign/AdobeStock

The Impact of Selective Serotonin Reuptake Inhibitors on Bleeding Risk: A Comprehensive Review

ByParas Gupta, MBE,Sarah Hakam, BS,Arsalan Nisar, MS,Inna D'Empaire, MD,Gina Jamal, MD,Reza Safavi, MD

February 3rd 2025

What patients are at risk when taking SSRIs?

Latest Updated Articles

The Impact of Selective Serotonin Reuptake Inhibitors on Bleeding Risk: A Comprehensive Review
February 3rd 2025

Trending on Psychiatric Times

What Clinicians Need to Know About Postpartum Psychosis

Brain Trust: Therapeutic Drug Monitoring and Adherence in Schizophrenia, With Jonathan M. Meyer, MD

Nature vs Nurture: The Interplay Between Genetics and Environmental Influences

AI as a Task-Replacing Tool for Psychiatric Care: A Conversation With Christoph Correll, MD

Reframing Long-Acting Injectable Antipsychotics as a Path to Patient Autonomy